Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial
Author
Bourgeois, FlorenceDoshi, Peter
Hong, Kyungwan
Jefferson, Tom
Jones, Mark
Lee, Haeyoung
Rowhani-Farid, Anisa
Shamseer, Larissa
Spence, O'Mareen

Date
2020-11-04Journal
mSpherePublisher
American Society for MicrobiologyType
Other
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/14101ae974a485f413a2113503eed53cd6c53
10.1128/mSphere.00770-20
Scopus Count
Related articles
- Reply to Bourgeois et al., "Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial".
- Authors: Garland SM, Steben M
- Issue date: 2020 Nov 4
- Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology.
- Authors: Doshi P, Bourgeois F, Hong K, Jones M, Lee H, Shamseer L, Spence O, Jefferson T
- Issue date: 2020 Dec
- Safety, tolerability, and immunogenicity of gardasil given concomitantly with Menactra and Adacel.
- Authors: Reisinger KS, Block SL, Collins-Ogle M, Marchant C, Catlett M, Radley D, Sings HL, Haupt RM, Garner EI, Protocol 025 Investigators.
- Issue date: 2010 Jun
- Gardasil 9 joins the fight against cervix cancer.
- Authors: Cuzick J
- Issue date: 2015
- An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
- Authors: Vesikari T, Van Damme P, Lindblad N, Pfletschinger U, Radley D, Ryan D, Vuocolo S, Haupt RM, Guris D
- Issue date: 2010 Apr